HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

Gastric CancerPeritoneal Metastases

Interventions

COMBINATION_PRODUCT

HIPEC

HIPEC after gastrectomy with D2 local lymph node dissection.

All Listed Sponsors

lead

Zhixin Cao

OTHER

NCT05300945 - HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter